1. Executive Summary
1.1. Global Sterile Injectable Contract Manufacturing Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2022
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. Covid-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Sterile Injectable Contract Manufacturing Market Outlook, 2018 - 2030
3.1. Global Sterile Injectable Contract Manufacturing Market Outlook, by Molecule Type, Value (US$ Bn), 2018 - 2030
3.1.1. Key Highlights
3.1.1.1. Small Molecule
3.1.1.2. Large Molecule
3.2. Global Sterile Injectable Contract Manufacturing Market Outlook, by Therapeutic Application, Value (US$ Bn), 2018 - 2030
3.2.1. Key Highlights
3.2.1.1. Cancer
3.2.1.2. Diabetes
3.2.1.3. Cardiovascular Diseases
3.2.1.4. Central Nervous System Disorders
3.2.1.5. Infectious Disorders
3.2.1.6. Musculoskeletal
3.2.1.7. Others
3.3. Global Sterile Injectable Contract Manufacturing Market Outlook, by Route of Administration, Value (US$ Bn), 2018 - 2030
3.3.1. Key Highlights
3.3.1.1. Subcutaneous (SC)
3.3.1.2. Intravenous (IV)
3.3.1.3. Intramuscular (IM)
3.3.1.4. Intrathecal
3.3.1.5. Others
3.4. Global Sterile Injectable Contract Manufacturing Market Outlook, by Region, Value (US$ Bn), 2018 - 2030
3.4.1. Key Highlights
3.4.1.1. North America
3.4.1.2. Europe
3.4.1.3. Asia Pacific
3.4.1.4. Latin America
3.4.1.5. Middle East & Africa
4. North America Sterile Injectable Contract Manufacturing Market Outlook, 2018 - 2030
4.1. North America Sterile Injectable Contract Manufacturing Market Outlook, by Molecule Type, Value (US$ Bn), 2018 - 2030
4.1.1. Key Highlights
4.1.1.1. Small Molecule
4.1.1.2. Large Molecule
4.2. North America Sterile Injectable Contract Manufacturing Market Outlook, by Therapeutic Application, Value (US$ Bn), 2018 - 2030
4.2.1. Key Highlights
4.2.1.1. Cancer
4.2.1.2. Diabetes
4.2.1.3. Cardiovascular Diseases
4.2.1.4. Central Nervous System Disorders
4.2.1.5. Infectious Disorders
4.2.1.6. Musculoskeletal
4.2.1.7. Others
4.3. North America Sterile Injectable Contract Manufacturing Market Outlook, by Route of Administration, Value (US$ Bn), 2018 - 2030
4.3.1. Key Highlights
4.3.1.1. Subcutaneous (SC)
4.3.1.2. Intravenous (IV)
4.3.1.3. Intramuscular (IM)
4.3.1.4. Intrathecal
4.3.1.5. Others
4.4. North America Sterile Injectable Contract Manufacturing Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
4.4.1. Key Highlights
4.4.1.1. U.S. Sterile Injectable Contract Manufacturing Market by Molecule Type, Value (US$ Bn), 2018 - 2030
4.4.1.2. U.S. Sterile Injectable Contract Manufacturing Market by Therapeutic Application, Value (US$ Bn), 2018 - 2030
4.4.1.3. U.S. Sterile Injectable Contract Manufacturing Market by Route of Administration, Value (US$ Bn), 2018 - 2030
4.4.1.4. Canada Sterile Injectable Contract Manufacturing Market by Molecule Type, Value (US$ Bn), 2018 - 2030
4.4.1.5. Canada Sterile Injectable Contract Manufacturing Market by Therapeutic Application, Value (US$ Bn), 2018 - 2030
4.4.1.6. Canada Sterile Injectable Contract Manufacturing Market by Route of Administration, Value (US$ Bn), 2018 - 2030
4.4.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Sterile Injectable Contract Manufacturing Market Outlook, 2018 - 2030
5.1. Europe Sterile Injectable Contract Manufacturing Market Outlook, by Molecule Type, Value (US$ Bn), 2018 - 2030
5.1.1. Key Highlights
5.1.1.1. Small Molecule
5.1.1.2. Large Molecule
5.2. Europe Sterile Injectable Contract Manufacturing Market Outlook, by Therapeutic Application, Value (US$ Bn), 2018 - 2030
5.2.1. Key Highlights
5.2.1.1. Cancer
5.2.1.2. Diabetes
5.2.1.3. Cardiovascular Diseases
5.2.1.4. Central Nervous System Disorders
5.2.1.5. Infectious Disorders
5.2.1.6. Musculoskeletal
5.2.1.7. Others
5.3. Europe Sterile Injectable Contract Manufacturing Market Outlook, by Route of Administration, Value (US$ Bn), 2018 - 2030
5.3.1. Key Highlights
5.3.1.1. Subcutaneous (SC)
5.3.1.2. Intravenous (IV)
5.3.1.3. Intramuscular (IM)
5.3.1.4. Intrathecal
5.3.1.5. Others
5.4. Europe Sterile Injectable Contract Manufacturing Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
5.4.1. Key Highlights
5.4.1.1. Germany Sterile Injectable Contract Manufacturing Market by Molecule Type, Value (US$ Bn), 2018 - 2030
5.4.1.2. Germany Sterile Injectable Contract Manufacturing Market by Therapeutic Application, Value (US$ Bn), 2018 - 2030
5.4.1.3. Germany Sterile Injectable Contract Manufacturing Market by Route of Administration, Value (US$ Bn), 2018 - 2030
5.4.1.4. U.K. Sterile Injectable Contract Manufacturing Market by Molecule Type, Value (US$ Bn), 2018 - 2030
5.4.1.5. U.K. Sterile Injectable Contract Manufacturing Market by Therapeutic Application, Value (US$ Bn), 2018 - 2030
5.4.1.6. U.K. Sterile Injectable Contract Manufacturing Market by Route of Administration, Value (US$ Bn), 2018 - 2030
5.4.1.7. France Sterile Injectable Contract Manufacturing Market By Molecule Type, Value (US$ Bn), 2018 - 2030
5.4.1.8. France Sterile Injectable Contract Manufacturing Market By Therapeutic Application, Value (US$ Bn), 2018 - 2030
5.4.1.9. France Sterile Injectable Contract Manufacturing Market By Route of Administration, Value (US$ Bn), 2018 - 2030
5.4.1.10. Italy Sterile Injectable Contract Manufacturing Market By Molecule Type, Value (US$ Bn), 2018 - 2030
5.4.1.11. Italy Sterile Injectable Contract Manufacturing Market By Therapeutic Application, Value (US$ Bn), 2018 - 2030
5.4.1.12. Italy Sterile Injectable Contract Manufacturing Market By Route of Administration, Value (US$ Bn), 2018 - 2030
5.4.1.13. Turkey Sterile Injectable Contract Manufacturing Market By Molecule Type, Value (US$ Bn), 2018 - 2030
5.4.1.14. Turkey Sterile Injectable Contract Manufacturing Market By Therapeutic Application, Value (US$ Bn), 2018 - 2030
5.4.1.15. Turkey Sterile Injectable Contract Manufacturing Market By Route of Administration, Value (US$ Bn), 2018 - 2030
5.4.1.16. Russia Sterile Injectable Contract Manufacturing Market By Molecule Type, Value (US$ Bn), 2018 - 2030
5.4.1.17. Russia Sterile Injectable Contract Manufacturing Market By Therapeutic Application, Value (US$ Bn), 2018 - 2030
5.4.1.18. Russia Sterile Injectable Contract Manufacturing Market By Route of Administration, Value (US$ Bn), 2018 - 2030
5.4.1.19. Rest Of Europe Sterile Injectable Contract Manufacturing Market By Molecule Type, Value (US$ Bn), 2018 - 2030
5.4.1.20. Rest Of Europe Sterile Injectable Contract Manufacturing Market By Therapeutic Application, Value (US$ Bn), 2018 - 2030
5.4.1.21. Rest Of Europe Sterile Injectable Contract Manufacturing Market By Route of Administration, Value (US$ Bn), 2018 - 2030
5.4.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Sterile Injectable Contract Manufacturing Market Outlook, 2018 - 2030
6.1. Asia Pacific Sterile Injectable Contract Manufacturing Market Outlook, by Molecule Type, Value (US$ Bn), 2018 - 2030
6.1.1. Key Highlights
6.1.1.1. Small Molecule
6.1.1.2. Large Molecule
6.2. Asia Pacific Sterile Injectable Contract Manufacturing Market Outlook, by Therapeutic Application, Value (US$ Bn), 2018 - 2030
6.2.1. Key Highlights
6.2.1.1. Cancer
6.2.1.2. Diabetes
6.2.1.3. Cardiovascular Diseases
6.2.1.4. Central Nervous System Disorders
6.2.1.5. Infectious Disorders
6.2.1.6. Musculoskeletal
6.2.1.7. Others
6.3. Asia Pacific Sterile Injectable Contract Manufacturing Market Outlook, by Route of Administration, Value (US$ Bn), 2018 - 2030
6.3.1. Key Highlights
6.3.1.1. Subcutaneous (SC)
6.3.1.2. Intravenous (IV)
6.3.1.3. Intramuscular (IM)
6.3.1.4. Intrathecal
6.3.1.5. Others
6.4. Asia Pacific Sterile Injectable Contract Manufacturing Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
6.4.1. Key Highlights
6.4.1.1. China Sterile Injectable Contract Manufacturing Market by Molecule Type, Value (US$ Bn), 2018 - 2030
6.4.1.2. China Sterile Injectable Contract Manufacturing Market by Therapeutic Application, Value (US$ Bn), 2018 - 2030
6.4.1.3. China Sterile Injectable Contract Manufacturing Market by Route of Administration, Value (US$ Bn), 2018 - 2030
6.4.1.4. Japan Sterile Injectable Contract Manufacturing Market by Molecule Type, Value (US$ Bn), 2018 - 2030
6.4.1.5. Japan Sterile Injectable Contract Manufacturing Market by Therapeutic Application, Value (US$ Bn), 2018 - 2030
6.4.1.6. Japan Sterile Injectable Contract Manufacturing Market by Route of Administration, Value (US$ Bn), 2018 - 2030
6.4.1.7. South Korea Sterile Injectable Contract Manufacturing Market by Molecule Type, Value (US$ Bn), 2018 - 2030
6.4.1.8. South Korea Sterile Injectable Contract Manufacturing Market by Therapeutic Application, Value (US$ Bn), 2018 - 2030
6.4.1.9. South Korea Sterile Injectable Contract Manufacturing Market by Route of Administration, Value (US$ Bn), 2018 - 2030
6.4.1.10. India Sterile Injectable Contract Manufacturing Market by Molecule Type, Value (US$ Bn), 2018 - 2030
6.4.1.11. India Sterile Injectable Contract Manufacturing Market by Therapeutic Application, Value (US$ Bn), 2018 - 2030
6.4.1.12. India Sterile Injectable Contract Manufacturing Market by Route of Administration, Value (US$ Bn), 2018 - 2030
6.4.1.13. Southeast Asia Sterile Injectable Contract Manufacturing Market by Molecule Type, Value (US$ Bn), 2018 - 2030
6.4.1.14. Southeast Asia Sterile Injectable Contract Manufacturing Market by Therapeutic Application, Value (US$ Bn), 2018 - 2030
6.4.1.15. Southeast Asia Sterile Injectable Contract Manufacturing Market by Route of Administration, Value (US$ Bn), 2018 - 2030
6.4.1.16. Rest of Asia Pacific Sterile Injectable Contract Manufacturing Market by Molecule Type, Value (US$ Bn), 2018 - 2030
6.4.1.17. Rest of Asia Pacific Sterile Injectable Contract Manufacturing Market by Therapeutic Application, Value (US$ Bn), 2018 - 2030
6.4.1.18. Rest of Asia Pacific Sterile Injectable Contract Manufacturing Market by Route of Administration, Value (US$ Bn), 2018 - 2030
6.4.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Sterile Injectable Contract Manufacturing Market Outlook, 2018 - 2030
7.1. Latin America Sterile Injectable Contract Manufacturing Market Outlook, by Molecule Type, Value (US$ Bn), 2018 - 2030
7.1.1. Key Highlights
7.1.1.1. Small Molecule
7.1.1.2. Large Molecule
7.2. Latin America Sterile Injectable Contract Manufacturing Market Outlook, by Therapeutic Application, Value (US$ Bn), 2018 - 2030
7.2.1. Key Highlights
7.2.1.1. Cancer
7.2.1.2. Diabetes
7.2.1.3. Cardiovascular Diseases
7.2.1.4. Central Nervous System Disorders
7.2.1.5. Infectious Disorders
7.2.1.6. Musculoskeletal
7.2.1.7. Others
7.3. Latin America Sterile Injectable Contract Manufacturing Market Outlook, by Route of Administration, Value (US$ Bn), 2018 - 2030
7.3.1. Key Highlights
7.3.1.1. Subcutaneous (SC)
7.3.1.2. Intravenous (IV)
7.3.1.3. Intramuscular (IM)
7.3.1.4. Intrathecal
7.3.1.5. Others
7.4. Latin America Sterile Injectable Contract Manufacturing Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
7.4.1. Key Highlights
7.4.1.1. Brazil Sterile Injectable Contract Manufacturing Market by Molecule Type, Value (US$ Bn), 2018 - 2030
7.4.1.2. Brazil Sterile Injectable Contract Manufacturing Market by Therapeutic Application, Value (US$ Bn), 2018 - 2030
7.4.1.3. Brazil Sterile Injectable Contract Manufacturing Market by Route of Administration, Value (US$ Bn), 2018 - 2030
7.4.1.4. Mexico Sterile Injectable Contract Manufacturing Market by Molecule Type, Value (US$ Bn), 2018 - 2030
7.4.1.5. Mexico Sterile Injectable Contract Manufacturing Market by Therapeutic Application, Value (US$ Bn), 2018 - 2030
7.4.1.6. Mexico Sterile Injectable Contract Manufacturing Market by Route of Administration, Value (US$ Bn), 2018 - 2030
7.4.1.7. Argentina Sterile Injectable Contract Manufacturing Market by Molecule Type, Value (US$ Bn), 2018 - 2030
7.4.1.8. Argentina Sterile Injectable Contract Manufacturing Market by Therapeutic Application, Value (US$ Bn), 2018 - 2030
7.4.1.9. Argentina Sterile Injectable Contract Manufacturing Market by Route of Administration, Value (US$ Bn), 2018 - 2030
7.4.1.10. Rest of Latin America Sterile Injectable Contract Manufacturing Market by Molecule Type, Value (US$ Bn), 2018 - 2030
7.4.1.11. Rest of Latin America Sterile Injectable Contract Manufacturing Market by Therapeutic Application, Value (US$ Bn), 2018 - 2030
7.4.1.12. Rest of Latin America Sterile Injectable Contract Manufacturing Market by Route of Administration, Value (US$ Bn), 2018 - 2030
7.4.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Sterile Injectable Contract Manufacturing Market Outlook, 2018 - 2030
8.1. Middle East & Africa Sterile Injectable Contract Manufacturing Market Outlook, by Molecule Type, Value (US$ Bn), 2018 - 2030
8.1.1. Key Highlights
8.1.1.1. Small Molecule
8.1.1.2. Large Molecule
8.2. Middle East Sterile Injectable Contract Manufacturing Market Outlook, by Therapeutic Application, Value (US$ Bn), 2018 - 2030
8.2.1. Key Highlights
8.2.1.1. Cancer
8.2.1.2. Diabetes
8.2.1.3. Cardiovascular Diseases
8.2.1.4. Central Nervous System Disorders
8.2.1.5. Infectious Disorders
8.2.1.6. Musculoskeletal
8.2.1.7. Others
8.3. Middle East & Africa Sterile Injectable Contract Manufacturing Market Outlook, by Route of Administration, Value (US$ Bn), 2018 - 2030
8.3.1. Key Highlights
8.3.1.1. Subcutaneous (SC)
8.3.1.2. Intravenous (IV)
8.3.1.3. Intramuscular (IM)
8.3.1.4. Intrathecal
8.3.1.5. Others
8.4. Middle East & Africa Sterile Injectable Contract Manufacturing Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
8.4.1. Key Highlights
8.4.1.1. GCC Sterile Injectable Contract Manufacturing Market by Molecule Type, Value (US$ Bn), 2018 - 2030
8.4.1.2. GCC Sterile Injectable Contract Manufacturing Market by Therapeutic Application, Value (US$ Bn), 2018 - 2030
8.4.1.3. GCC Sterile Injectable Contract Manufacturing Market by Route of Administration, Value (US$ Bn), 2018 - 2030
8.4.1.4. South Africa Sterile Injectable Contract Manufacturing Market by Molecule Type, Value (US$ Bn), 2018 - 2030
8.4.1.5. South Africa Sterile Injectable Contract Manufacturing Market by Therapeutic Application, Value (US$ Bn), 2018 - 2030
8.4.1.6. South Africa Sterile Injectable Contract Manufacturing Market by Route of Administration, Value (US$ Bn), 2018 - 2030
8.4.1.7. Egypt Sterile Injectable Contract Manufacturing Market by Molecule Type, Value (US$ Bn), 2018 - 2030
8.4.1.8. Egypt Sterile Injectable Contract Manufacturing Market by Therapeutic Application, Value (US$ Bn), 2018 - 2030
8.4.1.9. Egypt Sterile Injectable Contract Manufacturing Market by Route of Administration, Value (US$ Bn), 2018 - 2030
8.4.1.10. Nigeria Sterile Injectable Contract Manufacturing Market by Molecule Type, Value (US$ Bn), 2018 - 2030
8.4.1.11. Nigeria Sterile Injectable Contract Manufacturing Market by Therapeutic Application, Value (US$ Bn), 2018 - 2030
8.4.1.12. Nigeria Sterile Injectable Contract Manufacturing Market by Route of Administration, Value (US$ Bn), 2018 - 2030
8.4.1.13. Rest of Middle East & Africa Sterile Injectable Contract Manufacturing Market by Molecule Type, Value (US$ Bn), 2018 - 2030
8.4.1.14. Rest of Middle East & Africa Sterile Injectable Contract Manufacturing Market by Therapeutic Application, Value (US$ Bn), 2018 - 2030
8.4.1.15. Rest of Middle East & Africa Sterile Injectable Contract Manufacturing Market by Route of Administration, Value (US$ Bn), 2018 - 2030
8.4.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Manufacturer vs Application Heatmap
9.2. Company Market Share Analysis, 2022
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. Baxter
9.4.1.1. Company Overview
9.4.1.2. Molecule Type Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Development
9.4.2. Catalent, Inc.
9.4.2.1. Company Overview
9.4.2.2. Molecule Type Portfolio
9.4.2.3. Financial Overview
9.4.2.4. Business Strategies and Development
9.4.3. Boehringer Ingelheim
9.4.3.1. Company Overview
9.4.3.2. Molecule Type Portfolio
9.4.3.3. Financial Overview
9.4.3.4. Business Strategies and Development
9.4.4. Recipharm AB
9.4.4.1. Company Overview
9.4.4.2. Molecule Type Portfolio
9.4.4.3. Financial Overview
9.4.4.4. Business Strategies and Development
9.4.5. Aenova Group
9.4.5.1. Company Overview
9.4.5.2. Molecule Type Portfolio
9.4.5.3. Financial Overview
9.4.5.4. Business Strategies and Development
9.4.6. Fresenius Kabi
9.4.6.1. Company Overview
9.4.6.2. Molecule Type Portfolio
9.4.6.3. Financial Overview
9.4.6.4. Business Strategies and Development
9.4.7. Famar
9.4.7.1. Company Overview
9.4.7.2. Molecule Type Portfolio
9.4.7.3. Financial Overview
9.4.7.4. Business Strategies and Development
9.4.8. Grifols S.A
9.4.8.1. Company Overview
9.4.8.2. Molecule Type Portfolio
9.4.8.3. Financial Overview
9.4.8.4. Business Strategies and Development
9.4.9. Cipla Ltd.
9.4.9.1. Company Overview
9.4.9.2. Molecule Type Portfolio
9.4.9.3. Financial Overview
9.4.9.4. Business Strategies and Development
9.4.10. NextPharma Technologies
9.4.10.1. Company Overview
9.4.10.2. Molecule Type Portfolio
9.4.10.3. Financial Overview
9.4.10.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations